OptimizeRx Corporation

OptimizeRx Corporation

OptimizeRx Corporation provides a platform that helps healthcare professionals and patients to better engage with pharmaceutical companies.

Stock Performance Snapshot

Buy

Analyst Rating

Analysts suggest buying OptimizeRx stock as it has potential to rise to $12.36.

Above Average

Financial Health

OptimizeRx Corporation is performing well with strong revenue and profit margins, indicating good financial health.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring OPRX

Supply Chain Stocks: May Tariff Impacts Drive Growth?

Supply Chain Stocks: May Tariff Impacts Drive Growth?

The continued contraction of the U.S. manufacturing sector, heavily influenced by tariff wars, underscores the challenges facing domestic producers. This environment may create investment opportunities in companies that provide solutions for supply chain optimization and cost reduction.

Published: September 3, 2025

Explore Basket
Pharma's Digital Prescription

Pharma's Digital Prescription

Novo Nordisk is partnering with GoodRx to offer its popular drug Ozempic at a reduced price, boosting GoodRx's stock. This collaboration highlights a growing trend of pharmaceutical companies leveraging digital health platforms to improve drug affordability and expand market reach.

Published: August 19, 2025

Explore Basket
The Corporate Efficiency Drive

The Corporate Efficiency Drive

Starbucks announced a modest, standardized raise for its salaried employees as part of a broader cost-control and operational efficiency strategy. This move signals a potential investment opportunity in companies providing business optimization and cost-saving solutions to large corporations.

Published: August 19, 2025

Explore Basket
Navigating Pharma Price Controls

Navigating Pharma Price Controls

President Trump's ultimatum to major pharmaceutical firms to lower drug prices creates significant market uncertainty for brand-name drug makers. This situation could benefit companies that thrive on reducing healthcare costs, such as generic drug manufacturers and prescription discount platforms.

Published: August 4, 2025

Explore Basket
Digital Therapeutics & Prescription Apps

Digital Therapeutics & Prescription Apps

Software is becoming the new medicine. These carefully selected companies are developing FDA-cleared applications that treat everything from mental health to diabetes. With growing insurance reimbursement and massive scalability, these digital treatments represent healthcare's next frontier.

Published: June 17, 2025

Explore Basket
Digital Therapeutics

Digital Therapeutics

Software that works like medicine. These companies are creating clinically validated digital tools that treat and manage diseases just like traditional pharmaceuticals, but with the scalability of technology. Professional investors see enormous potential in this rapidly evolving healthcare frontier.

Published: June 17, 2025

Explore Basket
Bio-Hacking Portfolio

Bio-Hacking Portfolio

Discover companies at the cutting edge of human optimization, where biology meets technology. These carefully selected stocks represent innovators developing data-driven solutions for personalized health, enhanced performance, and extended longevity.

Published: June 17, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Point-of-care reach

The platform delivers messages and savings at prescribing moments, which can influence uptake — though adoption and regulation can affect outcomes.

🌍

Partner network growth

Engagement with pharma and health systems could scale campaign revenue, but competition and integration complexity are important considerations.

Execution and funding

As a small‑cap technology business, progress relies on execution and prudent finances; volatility and potential funding needs are risks to watch.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

MSFT

Microsoft Corporation

Microsoft is a tech company that develops, manufactures, licenses, supports, and sells computer software, consumer electronics, personal computers, and related services.

GOOG

Alphabet Inc. - Class C Shares

Alphabet Inc. - Class C Shares is a technology company that offers web-based services, digital media, cloud computing and other services.

GOOGL

Alphabet Inc (Google)

Alphabet - A is a technology company that offers web-based services, digital media, cloud computing and other services.

Frequently asked questions